Chemoinformaics analysis of alpha-D-Xylofuranoside, methyl 2,3-di-O-methyl-
| Molecular Weight | 192.211 | nRot | 4 |
| Heavy Atom Molecular Weight | 176.083 | nRig | 5 |
| Exact Molecular Weight | 192.1 | nRing | 1 |
| Solubility: LogS | 0.662 | nHRing | 1 |
| Solubility: LogP | -0.603 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 28.0387 |
| nHD | 1 | BPOL | 22.9953 |
| QED | 0.643 |
| Synth | 3.575 |
| Natural Product Likeliness | 2.103 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.035 |
| HIA | 0.12 |
| CACO-2 | -4.901 |
| MDCK | 0.000157013 |
| BBB | 0.245 |
| PPB | 0.105109 |
| VDSS | 0.805 |
| FU | 0.853757 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.728 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.688 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.017 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.177 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.304 |
| CL | 3.37 |
| T12 | 0.373 |
| hERG | 0.029 |
| Ames | 0.453 |
| ROA | 0.145 |
| SkinSen | 0.147 |
| Carcinogencity | 0.069 |
| EI | 0.147 |
| Respiratory | 0.019 |
| NR-Aromatase | 0.017 |
| Antiviral | No |
| Prediction | 0.927275 |